Icon

ORILISSA (nda210450)- (EQ 150MG BASE,EQ 200MG BASE)

ELAGOLIX SODIUM ABBVIE
EQ 150MG BASE,EQ 200MG BASE
Yes No
2040-Aug-27 2023-Jul-23
None None
None No
ORILISSA is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the management of moderate to severe pain associated with endometriosis.
0 1 0
Total Other Developers 25
Drugs with Suitability No
EQ 150MG BASE ** ** Up - -
EQ 200MG BASE ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.